Consistent with our hypothesis, we found that the addition of BAPTA-AM significantly inhibited pevonedistat-induced p-ERK1/2 activation in all three ALL cell lines examined (Figure 1C), supporting a mechanistic role of Ca2+ in mediating MEK-ERK pathway activation in pevonedistat-treated ALL cells. Here, MAPK3 is linked to acute lymphoblastic leukemia.